---
title: "FDA leadership void after Overton withdrawal; FDA rejects lung cancer drug and STAT ranks China’s"
id: "stat-news-1-fda-s-search-for-a-new-leader-and-china-s-largest-drugmakers"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-1-fda-s-search-for-a-new-leader-and-china-s-largest-drugmakers"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/11/20/new-fda-commissioner-summit-lung-cancer-drug-readout-loud-podcast/?utm_campaign=rss"
published_at: "2026-11-20T09:30:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# FDA leadership void after Overton withdrawal; FDA rejects lung cancer drug and STAT ranks China’s
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-1-fda-s-search-for-a-new-leader-and-china-s-largest-drugmakers
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/11/20/new-fda-commissioner-summit-lung-cancer-drug-readout-loud-podcast/?utm_campaign=rss)
- **Published At:** 2026-11-20T09:30:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The Trump administration withdrew the nomination of Heidi Overton to lead the **FDA** just hours before a Senate committee vote, leaving the agency without a confirmed new commissioner and prompting fresh questions about next candidates. - STAT reporters said D.C. correspondent Margaret Manto joined the podcast to explain why Overton was removed and to outline who might be considered next; the piece did not list specific successor names. - The FDA disclosed a rejection of the lung cancer therapy **ivonescimab**, developed by **Summit Therapeutics** in partnership with the Chinese firm Akeso; the article referenced a linked item with the agency’s stated reasons. - The authors noted the ivonescimab decision as a major regulatory setback for the program; the JINA source did not provide detailed clinical data, trial endpoints, or the precise regulatory rationale within the main write-up. - STAT launched a new index that ranks the 25 most valuable publicly traded Chinese drugmakers, labeled the “China’s Biotech Powerhouse 25.” - The podcast episode (pre-Thanksgiving) covered three themes: the FDA leadership search, the lung cancer drug rejection, and the new China biotech index; listeners were directed to the index page and to subscribe to The Readout LOUD. - The source did not report the methodology for the China ranking in the article text; readers were referred to the index link for details. - The team — Adam Feuerstein, Elaine Chen, and Damian Garde — presented the news in podcast form and invited listeners to follow on Apple Podcasts, Spotify, or other platforms. - The write-up tied these items to broader coverage beats: regulatory developments, oncology drug approvals, and the growing importance of Chinese biotech companies in global drug development. - Limitations in the source: no trial-level data for ivonescimab, no named list of potential FDA commissioner replacements in the article, and no detailed ranking criteria for the China index included in the main story.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/11/20/new-fda-commissioner-summit-lung-cancer-drug-readout-loud-podcast/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/20/new-fda-commissioner-summit-lung-cancer-drug-readout-loud-podcast/?utm_campaign=rss) [Clinical trials](https://www.statnews.com/topic/clinical-trials/) [aging](https://www.statnews.com/topic/aging/) [research](https://www.statnews.com/topic/research/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT@JPM27](https://www.statnews.com/jpm-conference-stat-events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Trust in Science](https://www.statnews.com/trust-in-science/) * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Madness 2027](https://www.statnews.com/feature/stat-madness/apply/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) China's Biotech Powerhouse 25 We ranked the 25 most valuable publicly traded Chinese drugmakers [ See the list ](https://www.statnews.com/china-biotech-index-powerhouse-25/) Podcast[The Readout LOUD](https://www.statnews.com/category/readout-loud/) # FDA’s search for a new leader, and China’s largest drugmakers * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/20/new-fda-commissioner-summit-lung-cancer-drug-readout-loud-podcast/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2024/07/ROL_Rectangle-645x645.jpg) ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) ![](https://www.statnews.com/wp-content/uploads/2022/12/elaine-chen-avatar-round-80x80.png) ![](https://www.statnews.com/wp-content/uploads/2021/02/damian-g-avatar-small2-80x80.png) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/), [Elaine Chen](https://www.statnews.com/staff/elaine-chen/), and [Damian Garde](https://www.statnews.com/staff/damian-garde/) Nov. 20, 2026 ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 1. [](https://x.com/adamfeuerstein "X") adam.feuerstein@statnews.com Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast [The Readout Loud](https://www.statnews.com/category/readout-loud/) and author of the newsletter [Adam’s Biotech Scorecard.](https://www.statnews.com/signup/scorecard/) You can reach Adam on Signal at stataf.54. [Get email alerts for Adam FeuersteinSigned up for email alertsRemove email alerts](https://www.statnews.com/2026/11/20/new-fda-commissioner-summit-lung-cancer-drug-readout-loud-podcast/?utm_campaign=rss) [Subscribe](https://www.statnews.com/stat-plus/) or [log in](https://www.statnews.com/login/) to STAT+ to unlock email alerts ![](https://www.statnews.com/wp-content/uploads/2022/12/elaine-chen-avatar-round-80x80.png) [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) 1. [](https://www.linkedin.com/in/elaineywchen/ "Linkedin") 2. [](https://x.com/elaineywchen "X") elaine.chen@statnews.com Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes [The Readout newsletter](https://www.statnews.com/signup/readout/), and co-hosts STAT’s weekly biotech podcast, [The Readout Loud](https://www.statnews.com/category/readout-loud/). You can reach Elaine on Signal at elaineywchen.70. [Get email alerts for Elaine ChenSigned up for email alertsRemove email alerts](https://www.statnews.com/2026/11/20/new-fda-commissioner-summit-lung-cancer-drug-readout-loud-podcast/?utm_campaign=rss) [Subscribe](https://www.statnews.com/stat-plus/) or [log in](https://www.statnews.com/login/) to STAT+ to unlock email alerts ![](https://www.statnews.com/wp-content/uploads/2021/02/damian-g-avatar-small2-80x80.png) [Damian Garde](https://www.statnews.com/staff/damian-garde/) 1. [](https://x.com/damiangarde "X") damian.garde@statnews.com Damian covers the global drug industry and contributes to STAT’s industry-leading events. You can reach Damian on Signal at damiangarde.67. [Get email alerts for Damian GardeSigned up for email alertsRemove email alerts](https://www.statnews.com/2026/11/20/new-fda-commissioner-summit-lung-cancer-drug-readout-loud-podcast/?utm_campaign=rss) [Subscribe](https://www.statnews.com/stat-plus/) or [log in](https://www.statnews.com/login/) to STAT+ to unlock email alerts On this week’s episode of “The Readout LOUD”: The FDA is once again searching for a new leader, a closely tracked lung cancer drug suffers an FDA rejection, and China’s largest drugmakers ranked. We invite you to listen to this pre-Thanksgiving episode of your favorite biotech podcast, where our attention turns to D.C. The Trump administration withdrew the nomination of Heidi Overton to become the next FDA commissioner hours before a pivotal Senate committee vote. STAT’s D.C. correspondent Margaret Manto joins us to explain why Overton was tossed and who might be next in line to run the FDA. Advertisement We’ll also chatter away about this week’s news, including the FDA’s [rejection of a lung cancer drug](https://www.statnews.com/2026/11/18/biotech-news-fda-discloses-reasons-for-rejecting-summit-drug/) from the U.S.-based biotech Summit Therapeutics and the Chinese drug maker Akeso. And speaking of China, [STAT just launched a new index ranking China’s largest drugmakers](https://www.statnews.com/china-biotech-index-powerhouse-25/). We’ll discuss how the list was made and why tracking Chinese biotech has become so important. Make sure to subscribe to “The Readout LOUD” on [Apple Podcasts](https://podcasts.apple.com/us/podcast/the-readout-loud/id1354473987?mt=2), [Spotify](https://open.spotify.com/show/7c181EiST5DhX4Zh2kt7Tq), or wherever you get your podcasts. [biotechnology](https://www.statnews.com/topic/biotechnology/), [Cancer](https://www.statnews.com/topic/cancer/), [China](https://www.statnews.com/topic/china/), [FDA](https://www.statnews.com/topic/fda/), [Pharmaceuticals](https://www.statnews.com/topic/pharmaceuticals/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2021/02/adam-f-avatar-small2-80x80.png) [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 1. [](https://x.com/adamfeuerstein "X") 2. Senior Writer, Biotech 1. [](https://x.com/adamfeuerstein "X") 2. Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast [The Readout Loud](https://www.statnews.com/category/readout-loud/) and author of the newsletter [Adam’s Biotech Scorecard.](https://www.statnews.com/signup/scorecard/) You can reach Adam on Signal at stataf.54. 2. ![](https://www.statnews.com/wp-content/uploads/2022/12/elaine-chen-avatar-round-80x80.png) [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) 1. [](https://x.com/elaineywchen "X") 2. [](https://bsky.app/profile/elaineywchen.bsky.social "Bluesky") 3. 4. [](https://www.linkedin.com/in/elaineywchen/ "Linkedin") National Biotech Reporter 1. [](https://x.com/elaineywchen "X") 2. [](https://bsky.app/profile/elaineywchen.bsky.social "Bluesky") 3. 4. [](https://www.linkedin.com/in/elaineywchen/ "Linkedin") Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes [The Readout newsletter](https://www.statnews.com/signup/readout/), and co-hosts STAT’s weekly biotech podcast, [The Readout Loud](https://www.statnews.com/category/readout-loud/). You can reach Elaine on Signal at elaineywchen.70. 3. ![](https://www.statnews.com/wp-content/uploads/2021/02/damian-g-avatar-small2-80x80.png) [Damian Garde](https://www.statnews.com/staff/damian-garde/) 1. [](https://x.com/damiangarde "X") 2. Reporter at Large, Live and Feature Journalism 1. [](https://x.com/damiangarde "X") 2. Damian covers the global drug industry and contributes to STAT’s industry-leading events. You can reach Damian on Signal at damiangarde.67. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/The-Readout-Logo-Black-640x99.png) ### Newsletter Your morning rundown of the science, politics, and money driving biotech today Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/11/peps-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Peptide market poised to explode with new Hims and Noom launches](https://www.statnews.com/2026/11/19/hims-noom-enter-peptide-market-mainstream-products-health-risks/) 2. ![](https://www.statnews.com/wp-content/uploads/2025/09/TheWorkup_Illustration_MollyFerguson_093025-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [I’m a cardiologist. I’m a little puzzled about the blockbuster new study on deprescribing statins](https://www.statnews.com/2026/11/19/deprescribing-statins-study-stream-trial-aha-questions/) 3. ![](https://www.statnews.com/wp-content/uploads/2025/03/GettyImages-2187619311-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [UnitedHealth sues to reverse downgraded Medicare Advantage quality scores](https://www.statnews.com/2026/11/20/unitedhealth-cms-medicare-advantage-lawsuit-star-rating/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/10/AdobeStock_499879090-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [In cancer drug development, the spotlight shifts onto Erasca’s KRAS-targeted treatment](https://www.statnews.com/2026/11/19/erasca-kras-targeted-treatment-new-data-pancreatic-cancer/) 5. ![](https://www.statnews.com/wp-content/uploads/2024/03/AdobeStock_421143532_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Merck, Isomorphic Labs partner to develop oncology drug candidates](https://www.statnews.com/2026/11/19/merck-isomorphic-labs-partner-to-develop-oncology-drug-candidates/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/10/STATatHLTH_Wordpress_CalendarImage-80x80.jpg) STAT@hlth. A Dose of Reality on EHRs and AI In-person Nov 18 ](https://www.statnews.com/event/stathlth-a-dose-of-reality-on-ehrs-and-ai/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/2026ASH_Wordpress_CalendarImage-80x80.jpg) STAT@ASH: Medicine’s Bleeding Edge New Orleans, LA Dec 13 ](https://www.statnews.com/event/stat-at-ash-meeting-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/BTE2027_Wordpress_CalendarImage-80x80.jpg) 2027 Breakthrough Summit East New York City, NY Mar 18 ](https://www.statnews.com/event/2027-stat-breakthrough-summit-east/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2025/09/TheWorkup_Illustration_MollyFerguson_093025-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [I’m a cardiologist. I’m a little puzzled about the blockbuster new study on deprescribing statins](https://www.statnews.com/2026/11/19/deprescribing-statins-study-stream-trial-aha-questions/) 2. ![](https://www.statnews.com/wp-content/uploads/2024/09/GettyImages-1237273640-1-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA rejects lung cancer treatment ivonescimab from Summit Therapeutics](https://www.statnews.com/2026/11/15/fda-rejects-ivonescimab-lung-cancer-treatment-summit-therapeutics/) 3. ![](https://www.statnews.com/wp-content/uploads/2017/01/AP80889059-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Federal judge issues final ruling blocking U.S. plan to limit visa length for grad students, postdocs](https://www.statnews.com/2026/11/16/judge-rejects-visa-limits-international-researchers-upholds-duration-of-status-policy/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/11/AdobeStock_587333568_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [In a win for MAHA, FDA creates new regulatory category for the supplement NAC](https://www.statnews.com/2026/11/16/fda-proposes-new-category-supplement-nac/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/05/AP26023803702193-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Oura’s acquisition of health tech startup raises conflict-of-interest questions for Eli Lilly, experts say](https://www.statnews.com/2026/11/13/oura-acquisition-counsel-health-eli-lilly/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout LOUD The Readout LOUD November 13, 2026 ### [ The future of heart drug research in the wake of study setbacks ](https://www.statnews.com/2026/11/13/cardiovascular-disease-heart-drug-failures-readout-loud-podcast/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) and [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout LOUD The Readout LOUD Novem
## Related Clinical Research

- [Early STAT+ Results for Alterome’s KRAS Inhibitor in Pancreatic, Lung, and Colorectal Cancer](https://medichelpline.com/clinical-feed/stat-news-1-stat-early-results-for-alterome-s-kras-drug-for-pancreas-lung-and-colon-cancer.md)
- [Merck partners with Isomorphic Labs to discover small-molecule oncology candidates](https://medichelpline.com/clinical-feed/stat-news-3-stat-merck-isomorphic-labs-partner-to-develop-oncology-drug-candidates.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)
- [Later bedtimes and late eating tied to higher metabolic syndrome risk](https://medichelpline.com/clinical-feed/medical-news-today-0-eating-and-sleeping-later-associated-with-increased-health-risks.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.